The Wegovy Savings Card in 2026: Eligibility, the $0 vs $499 Copay Tiers, and How to Use It

Key Takeaways

• The Wegovy savings card lowers eligible commercial-insurance copays to as little as $0 per fill when Wegovy is covered, or to a flat $499 per month when it isn't.
• Patients on Medicare, Medicaid, TRICARE, or VA plans don't qualify.
• The card is offered by Novo Nordisk and is downloadable from the WeGoTogether website.
• Most patients searching for "wegovy savings card" don't realize there are effectively two different programs sharing the same card, depending on whether your insurance covers Wegovy.
• It went live in March 2025 as Novo Nordisk's response to the explosion of compounded semaglutide.

Direct answer (40-60 words)

The Wegovy savings card lowers eligible commercial-insurance copays to as little as $0 per fill when Wegovy is covered, or to a flat $499 per month when it isn't. Patients on Medicare, Medicaid, TRICARE, or VA plans don't qualify. The card is offered by Novo Nordisk and is downloadable from the WeGoTogether website.

Table of contents

1. The 30-second answer
2. The two Wegovy savings card tiers, side by side
3. Who qualifies (and who absolutely doesn't)
4. The $0 copay tier: when Wegovy is covered by your plan
5. The $499 cash tier: when your plan denies coverage
6. How to download and activate the card
7. How to use the card at the pharmacy counter
8. Annual and lifetime limits you should know
9. What to do if you don't qualify
10. Real-world cost scenarios
11. The compounded semaglutide alternative
12. FAQ
13. Footer disclaimers

The two Wegovy savings card tiers, side by side

Most patients searching for "wegovy savings card" don't realize there are effectively two different programs sharing the same card, depending on whether your insurance covers Wegovy.

Scenario	What you pay with the card	Annual savings cap	Eligibility requirement
Commercial insurance + Wegovy on formulary	As little as $0 per 28-day fill	Up to $225 per fill, max $3,500/year	Must have commercial insurance covering Wegovy
Commercial insurance + Wegovy NOT covered (or coverage denied)	$499 flat per 28-day supply	N/A (already discounted price)	Must have commercial insurance, even if it doesn't cover Wegovy
Medicare, Medicaid, TRICARE, VA, or government-funded plans	Not eligible	N/A	Federal anti-kickback rules block use
Uninsured	Not eligible for the savings card	N/A	Cash price is $1,349 list at most pharmacies

The $499 tier is sometimes called "Wegovy NovoCare Pharmacy" pricing. It went live in March 2025 as Novo Nordisk's response to the explosion of compounded semaglutide. Before that, patients without coverage paid the full $1,349 list price.

Who qualifies (and who absolutely doesn't)

Qualifying:

• U.S. residents (50 states + Puerto Rico, Washington D.C.)
• Patients with commercial insurance (employer-sponsored, marketplace, or self-purchased)
• Patients with a valid Wegovy prescription written for FDA-approved indications (chronic weight management in adults with BMI 30+, or BMI 27+ with at least one weight-related comorbidity, or in adolescents 12+ meeting criteria)
• Patients aged 12 or older

Not qualifying:

• Anyone enrolled in Medicare Part D, Medicare Advantage with Part D coverage
• Anyone with Medicaid (any state)
• TRICARE beneficiaries
• VA beneficiaries
• Indian Health Service beneficiaries
• Any other federal healthcare program participant
• Anyone whose primary insurance is government-funded

The Medicare exclusion is the most painful one for many patients. The federal anti-kickback statute prohibits manufacturer copay assistance for federally insured patients because the assistance could improperly steer prescribing toward branded products. There is no workaround. Patients on Medicare aged 65+ are excluded even if they have private supplemental coverage.

The Medicaid exclusion has the same legal basis. State Medicaid programs vary in whether they cover Wegovy at all (most don't cover anti-obesity medications, though this is changing slowly).

The $0 copay tier: when Wegovy is covered by your plan

If your commercial insurance plan has Wegovy on its formulary and approves the prior authorization, the savings card reduces your copay to as little as $0 per fill, up to $225 in savings per fill and a $3,500 annual maximum.

How the math works:

Say your insurance plan's negotiated price for Wegovy is $1,100, your formulary tier copay is $250, and your prior authorization is approved. Without the card, you'd pay $250. With the card:

• Card pays $225 of your $250 copay
• You pay $25

Another scenario: your copay is $150. With the card:

• Card pays $150 (capped at the actual copay amount)
• You pay $0

The card never pays more than $225 per fill and never more than $3,500 across a calendar year. If your annual copays would exceed those limits, you cover the difference.

Annual ceiling math: $3,500 / $225 max per fill = ~15.5 fills per year of maximum benefit. For a monthly fill (13 fills per year), you'd hit the cap if every fill triggered the $225 maximum. Most patients with mid-range copays use 12 to 13 fills of partial card benefit and stay under the annual ceiling.

Patients with high-deductible plans: The card works after the deductible is met. Until you meet the deductible, you typically pay the full negotiated rate at the pharmacy (often $1,000 to $1,300), and the card may pay $225 toward that. After the deductible is met, the card kicks in against the lower copay.

The $499 cash tier: when your plan denies coverage

This is the newer program (launched March 2025) and the one that has changed the math for most uninsured-or-denied patients in 2026.

Who pays $499:

• Patients with commercial insurance whose plan doesn't cover Wegovy at all
• Patients whose prior authorization was denied and the appeal failed
• Patients whose plan covers Wegovy but the copay is higher than $499 (rare but happens)

What you get:

• A 28-day supply (4 pens of escalating doses, or 4 pens at maintenance dose)
• Direct-ship from a Novo Nordisk-affiliated pharmacy (NovoCare Pharmacy)
• Same Wegovy product as pharmacies dispense to insurance-covered patients

How it differs from the standard pharmacy: The $499 tier is a direct-to-patient program. Wegovy is shipped to your home rather than picked up at a retail pharmacy. The pharmacy network is limited to Novo Nordisk-affiliated dispensaries.

What's required:

• Commercial insurance card (even if your plan denies Wegovy)
• A valid Wegovy prescription
• Sign-up at the NovoCare website
• Continued payment of $499 per month for ongoing fills

This program is the closest the brand-name market has come to compounded pricing. It's still notably more expensive than compounded semaglutide ($179 to $499 per month from telehealth platforms), but it gets brand-name Wegovy under $500 per month for many previously priced-out patients.

How to download and activate the card

The card is provided by Novo Nordisk. There's no sign-up fee, no income test, and no doctor approval required for the card itself (though the prescription comes from a clinician).

Steps:

1. Visit the WeGoTogether or NovoCare website (the URL shifts; search "Wegovy savings card" if needed).
2. Confirm eligibility: U.S. resident, age 12+, commercial insurance, valid Wegovy prescription.
3. Enter basic information: name, date of birth, ZIP code, insurance information.
4. Receive a digital card immediately. You can save it to a phone wallet or print it.
5. Bring the card to the pharmacy on your next fill.

For the $499 cash-pay tier, the process is different:

1. Confirm your prescription is on file.
2. Sign up at NovoCare Pharmacy.
3. Provide payment method.
4. Wegovy ships to your home in 5 to 10 business days.

How to use the card at the pharmacy counter

For the standard insurance-covered tier:

1. Hand the pharmacist your insurance card and your Wegovy savings card together.
2. The pharmacist runs your insurance first to establish the copay.
3. The pharmacist then runs the savings card as a secondary payer to reduce your copay.
4. You pay the remaining amount.

For the $499 NovoCare Pharmacy tier, you don't go through retail pharmacy. The medication ships directly from Novo Nordisk's affiliated pharmacy.

If the pharmacist says the card "doesn't work":

• Confirm your insurance card is current (some plans change pharmacy benefit managers mid-year).
• Confirm Wegovy is the prescription on file (not Ozempic, not Saxenda).
• Confirm prior authorization status. If PA hasn't been approved, the card can't reduce a copay because there's no in-network claim to discount against.
• Call the NovoCare patient support line.

Annual and lifetime limits you should know

Annual limit: $3,500 in savings card benefit per calendar year for the insurance-covered tier. The clock resets January 1.

Per-fill limit: Up to $225 per fill. If your copay is higher than $225 + your $0 paid (or whatever you'd pay), the card maxes out at $225 of help.

Lifetime limit: Currently no published lifetime cap. Novo Nordisk reserves the right to modify the program annually.

Eligibility window: The card is valid in the calendar year you activate it. Re-activation may be required at the start of each calendar year.

Limits don't apply to the $499 tier: That program is a flat cash price, not a copay reduction. There's no annual cap on use because nothing is being discounted; you're just paying the cash rate directly.

What to do if you don't qualify

If you're on Medicare, Medicaid, or another government plan, the savings card is off the table. Options:

Option 1: Patient Assistance Program (PAP). Novo Nordisk's PAP for low-income patients without commercial coverage. Income limit is 400% of federal poverty level (about $60,240 for an individual, $124,800 for a family of 4 in 2026). Provider-submitted application. Approval takes 5 to 10 business days. If approved, Wegovy is shipped free for up to 12 months at a time.

Option 2: Medicare alternative coverage check. Some Medicare Advantage plans cover Wegovy under specific medical necessity criteria. Your Part D plan's formulary tells you whether Wegovy is on the list. The 2026 Medicare expansion of GLP-1 coverage for cardiovascular indications (per the CMS Medicare Coverage of Anti-Obesity Medications proposed rule) may apply if you have ASCVD plus obesity.

Option 3: Compounded semaglutide. For patients without coverage and unable to afford the $499 tier, compounded semaglutide from a telehealth platform like FormBlends starts around $179 per month. See the why compounded semaglutide red guide for context on how compounded products differ from brand-name Wegovy.

Option 4: Clinical trial enrollment. Anti-obesity medication trials sometimes provide free study drug. ClinicalTrials.gov lists active trials by location.

Real-world cost scenarios

Scenario 1: Employer PPO with Wegovy coverage. Patient has BlueCross BlueShield through a tech employer. Wegovy is on Tier 3, copay $200 after deductible. Savings card reduces copay to $0 (card pays $200 of the $200 copay, capped at $225). Annual cost: $0 for 12 fills, plus any pre-deductible spending.

Scenario 2: Marketplace silver plan with no Wegovy coverage. Patient has a marketplace silver plan that excludes anti-obesity medications. Insurance won't cover Wegovy at all. Patient signs up for the $499 NovoCare Pharmacy tier. Monthly cost: $499. Annual cost: $5,988.

Scenario 3: Medicare Part D patient with type 2 diabetes. Patient is 68, on Medicare Part D, has type 2 diabetes plus obesity. Doctor prescribes Ozempic (covered by Medicare for diabetes) rather than Wegovy. Savings card unavailable. Monthly cost: $250 to $500 in Part D copay tier.

Scenario 4: Self-employed, commercial insurance, Wegovy denied. Patient is 42, owns a small business, has individual commercial insurance. Wegovy prior authorization denied because BMI is 28 with no comorbidity (under the 27+ threshold). Patient signs up for the $499 NovoCare Pharmacy tier. Monthly cost: $499.

Scenario 5: 12-year-old adolescent with severe obesity. Patient is 12, has BMI in the 99th percentile. Insurance covers Wegovy under pediatric obesity coverage. Savings card reduces copay to $0. Annual cost: $0 for 12 fills.

The compounded semaglutide alternative

For patients excluded from the savings card (Medicare, Medicaid, government plans) or for whom the $499 NovoCare tier still doesn't fit the budget, compounded semaglutide is the most common alternative.

Pricing comparison:

Option	Monthly cost	Eligibility
Wegovy + savings card (covered)	$0 to $225	Commercial insurance, Wegovy on formulary
Wegovy + NovoCare Pharmacy ($499 tier)	$499	Commercial insurance, no government coverage
Wegovy retail cash price	$1,349	Anyone (not eligible for savings card)
Compounded semaglutide (FormBlends)	$179 to $279	U.S. patient, valid prescription from licensed provider
Compounded semaglutide (other 503A pharmacies)	$150 to $499	Varies by pharmacy and platform

Compounded vs brand-name considerations:

• Compounded semaglutide is not FDA-approved. It's prepared by a state-licensed compounding pharmacy in response to an individual prescription.
• The active ingredient is the same chemical entity when sourced from FDA-registered API suppliers, but the finished product is not the same drug as Wegovy.
• The vial-and-syringe delivery format is different from Wegovy's pre-filled pen.
• Insurance does not reimburse compounded semaglutide.

For patients facing a $499/month or more out-of-pocket cost on brand-name Wegovy and who don't qualify for the savings card, the cost difference vs compounded options is significant.

FAQ

How much can the Wegovy savings card save me? Up to $225 per fill and up to $3,500 per calendar year for patients with commercial insurance plans that cover Wegovy. For patients whose plan doesn't cover Wegovy, the separate NovoCare Pharmacy program offers a flat $499 per 28-day supply.

Who is eligible for the Wegovy savings card? U.S. residents aged 12 or older with commercial insurance and a valid Wegovy prescription. Patients on Medicare, Medicaid, TRICARE, VA, or other federal healthcare programs are not eligible.

Why isn't the Wegovy savings card available for Medicare patients? Federal anti-kickback statutes prohibit manufacturer copay assistance for patients enrolled in federal healthcare programs. The same restriction applies to all manufacturer copay cards across all branded medications, not just Wegovy.

Can I use the savings card if my insurance denies Wegovy? Not for the $0 copay tier (which requires plan coverage). However, you can use the separate NovoCare Pharmacy $499 cash-pay program if you have commercial insurance and your plan denies coverage.

Does the Wegovy savings card work at any pharmacy? For the insurance-covered tier, yes, at most major retail pharmacies. For the $499 NovoCare Pharmacy tier, the medication ships directly from a Novo Nordisk-affiliated mail-order pharmacy.

How long is the Wegovy savings card valid? The card is valid for the calendar year of activation. You may need to re-activate at the start of each calendar year. The annual savings limit ($3,500 for the insurance-covered tier) resets January 1.

What's the difference between the Wegovy savings card and the NovoCare Pharmacy $499 program? The savings card reduces your insurance copay by up to $225 per fill when your plan covers Wegovy. The $499 program is a separate cash-pay direct-ship offering for patients whose insurance doesn't cover Wegovy. They are different programs sharing the same brand sponsor.

Is the $499 Wegovy NovoCare price available at retail pharmacies? No. The $499 tier is a direct-to-patient program. Wegovy at that price ships from Novo Nordisk's affiliated pharmacy, not from CVS, Walgreens, or Walmart.

Can I use the Wegovy savings card with a Health Savings Account (HSA)? Yes. Eligible Wegovy expenses (your remaining out-of-pocket cost after the savings card) can be paid with HSA or FSA funds.

Can children use the Wegovy savings card? Yes, for adolescents aged 12 and older with a valid Wegovy prescription for chronic weight management. Wegovy is FDA-approved for adolescents in this age range with BMI at or above the 95th percentile.

Will the Wegovy savings card cover Ozempic? No. Ozempic uses a separate Novo Nordisk savings card with different rules. They are different drugs (different doses, different indications), and the cards aren't interchangeable.

What happens if I switch jobs and lose my insurance mid-year? The savings card eligibility ends when your commercial insurance ends. If you transition to COBRA, the card continues to work. If you transition to Medicare, Medicaid, or no insurance, you'd switch to either the NovoCare Pharmacy $499 tier (still requires commercial insurance) or the Patient Assistance Program (for low-income uninsured).

How do I apply for the Patient Assistance Program if I'm uninsured? Visit the NovoCare website, complete the patient application form, and have your provider sign the medical necessity portion. Approval typically takes 5 to 10 business days. If approved, you receive Wegovy free for up to 12 months at a time, with renewal possible.

Is compounded semaglutide cheaper than the Wegovy savings card? For most patients, yes. Compounded semaglutide from telehealth platforms typically runs $179 to $499 per month with no insurance involvement. The Wegovy savings card $0 tier is cheapest for patients whose insurance covers Wegovy, but only about 30 to 40% of commercially insured patients have plans that cover Wegovy at a low copay.

Author / review note

Reviewed by the FormBlends Medical Team. References include the Novo Nordisk Wegovy prescribing information (rev. 2024), the WeGoTogether savings card terms and conditions (Q1 2026), the Centers for Medicare and Medicaid Services (CMS) anti-kickback statute as it applies to manufacturer copay programs, and the NovoCare Pharmacy direct-to-patient program (launched March 2025).

Sources

1. The Novo Nordisk Wegovy prescribing information (rev. 2024).
2. The WeGoTogether savings card terms and conditions (Q1 2026).
3. The Centers for Medicare and Medicaid Services (CMS) anti-kickback statute as it applies to manufacturer copay programs.
4. The NovoCare Pharmacy direct-to-patient program (launched March 2025).

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, Saxenda, and NovoCare are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.